Status:
COMPLETED
Incidence of The Bowel, Bladder, and Sexual Dysfunction Following Surgery for Colorectal Malignancy
Lead Sponsor:
National Academy of Medical Sciences, Nepal
Conditions:
Bowel Dysfunction
Bladder Dysfunction
Eligibility:
All Genders
18-75 years
Brief Summary
Colorectal cancer is the second most common cancer by the site in Europe and the third most common cancer in the USA with high morbidity and mortality. Survival after the treatment has improved over t...
Detailed Description
It was a cross-sectional study at Bir Hospital and the duration of the study was from December 2014 to December 2017. Here, all the patients who underwent LAR and APR following neoadjuvant chemoradiot...
Eligibility Criteria
Inclusion
- 1\) All the patients who underwent LAR and APR following neoadjuvant chemoradiotherapy.
Exclusion
- All the patients with recurrence after surgery,
- Lost to follow up,
- Benign disease,
- Patients who did not undergo neoadjuvant chemoradiotherapy, and
- Patients who underwent trans-anal excision.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04134104
Start Date
December 1 2014
End Date
December 1 2017
Last Update
November 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.